CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 143 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $488,619 | -55.7% | 41,798 | -37.2% | 0.00% | -75.0% |
Q1 2023 | $1,103,996 | +82.5% | 66,586 | -25.5% | 0.00% | +100.0% |
Q4 2021 | $605,000 | +73.4% | 89,336 | +17.9% | 0.00% | 0.0% |
Q1 2021 | $349,000 | +2.0% | 75,781 | -26.0% | 0.00% | -33.3% |
Q4 2020 | $342,000 | +79.1% | 102,356 | +59.3% | 0.00% | 0.0% |
Q3 2020 | $191,000 | -79.9% | 64,257 | -74.0% | 0.00% | -87.5% |
Q1 2020 | $952,000 | -74.7% | 247,194 | -75.4% | 0.02% | +9.1% |
Q4 2019 | $3,765,000 | +4789.6% | 1,004,042 | +6813.5% | 0.02% | +2100.0% |
Q3 2019 | $77,000 | -50.6% | 14,523 | -64.1% | 0.00% | -50.0% |
Q2 2019 | $156,000 | +79.3% | 40,500 | -10.3% | 0.00% | +100.0% |
Q4 2018 | $87,000 | -86.2% | 45,147 | -77.6% | 0.00% | -87.5% |
Q2 2018 | $629,000 | +104.9% | 201,450 | +56.8% | 0.01% | +60.0% |
Q1 2018 | $307,000 | -57.9% | 128,500 | -31.2% | 0.01% | -61.5% |
Q4 2017 | $730,000 | +276.3% | 186,643 | +142.7% | 0.01% | +225.0% |
Q3 2017 | $194,000 | +16.2% | 76,900 | +27.1% | 0.00% | +33.3% |
Q2 2017 | $167,000 | +778.9% | 60,500 | +236.1% | 0.00% | +200.0% |
Q4 2016 | $19,000 | -34.5% | 18,000 | -56.5% | 0.00% | -50.0% |
Q2 2016 | $29,000 | – | 41,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
XML Financial, LLC | 40,000 | $119,000 | 0.04% |